Published in Eur Arch Otorhinolaryngol on October 19, 2012
Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection. Eur Arch Otorhinolaryngol (2014) 0.78
Management of complications and compromised free flaps following major head and neck surgery. Eur Arch Otorhinolaryngol (2015) 0.77
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis (1974) 3.01
Contemporary reconstruction of the mandible. Oral Oncol (2009) 1.52
Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg (2004) 1.30
Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck (2007) 1.19
Free flap reconstruction of the head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg (2001) 1.18
Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg (2005) 1.17
Factors predicting free flap complications in head and neck reconstruction. J Plast Reconstr Aesthet Surg (2006) 1.15
Clinicopathologic and therapeutic risk factors for perioperative complications and prolonged hospital stay in free flap reconstruction of the head and neck. Head Neck (2010) 1.06
Basics in nutrition and wound healing. Nutrition (2010) 1.05
Free-flap head and neck reconstruction and quality of life: a 2-year prospective study. Laryngoscope (2008) 0.99
Gastroesophageal reflux prophylaxis decreases the incidence of pharyngocutaneous fistula after total laryngectomy. Laryngoscope (1995) 0.96
Factors influencing survival of free-flap in reconstruction for cancer of the head and neck: a literature review. Microsurgery (2010) 0.96
Closure of post-laryngectomy pharyngocutaneous fistulae. Head Neck Oncol (2011) 0.94
Incidence and prediction of major cardiovascular complications in head and neck surgery. Head Neck (2010) 0.94
Free flap reconstruction of lateral mandibular defects: indications and outcomes. Otolaryngol Head Neck Surg (2011) 0.91
Head and neck reconstruction with free flaps: a report on 213 cases. Eur Arch Otorhinolaryngol (2007) 0.91
Head and neck free-flap reconstruction in the elderly. Eur Ann Otorhinolaryngol Head Neck Dis (2011) 0.88
A prospective study on prognostic factors for free-flap reconstructions of head and neck defects. Int J Oral Maxillofac Surg (2009) 0.85
Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg (2009) 0.83
[Mandibular reconstruction with osseous free flaps: functional results]. Ann Otolaryngol Chir Cervicofac (2007) 0.83
[Transoral and cervical approach without mandibulotomy for oropharynx cancer with fasciocutaneous radial forearm free flap reconstruction]. Ann Otolaryngol Chir Cervicofac (2009) 0.80
Immunonutrition in head and neck cancer: have a look before surgery! Eur Arch Otorhinolaryngol (2011) 0.80
[Head and neck reconstructive surgery with free flaps and quality of life: a prospective study]. Rev Laryngol Otol Rhinol (Bord) (2007) 0.78
[Free-flap head and neck reconstruction failures: predictive factors and management]. Ann Chir Plast Esthet (2010) 0.78
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol (2008) 2.85
HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer (2007) 1.86
A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol (2004) 1.80
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer (2006) 1.65
Bilateral breast involvement in medullary thyroid carcinoma. Thyroid (2009) 1.50
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients. Radiother Oncol (2013) 1.49
Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma (2013) 1.49
Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol (2011) 1.41
Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res (2009) 1.34
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol (2014) 1.26
EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences. Crit Rev Oncol Hematol (2007) 1.21
Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol (2002) 1.19
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys (2006) 1.13
Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival. Cancer (2008) 1.03
A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Hum Mol Genet (2011) 1.02
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma. Cancer Res (2013) 1.01
Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol (2005) 1.00
Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Int J Radiat Oncol Biol Phys (2008) 1.00
Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg (2010) 1.00
MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells. Endocr Relat Cancer (2011) 1.00
Free-flap head and neck reconstruction and quality of life: a 2-year prospective study. Laryngoscope (2008) 0.99
Assessment of morphology, antigenicity, and nucleic acid integrity for diagnostic thyroid pathology using formalin substitute fixatives. Thyroid (2009) 0.96
Diplopia as the first symptom of an aggressive metastatic rectal stromal tumor. Onkologie (2009) 0.96
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number. Ann Surg Oncol (2007) 0.95
Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience. World J Surg Oncol (2009) 0.94
Randomised, multi-centre study of the usefulness of the heat and moisture exchanger (Provox HME®) in laryngectomised patients. Eur Arch Otorhinolaryngol (2011) 0.93
Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan? Cancer (2004) 0.92
Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer. Cancer (2006) 0.92
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer. Pharmacogenomics (2009) 0.92
Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors. Eur Arch Otorhinolaryngol (2009) 0.92
Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays. Thyroid (2014) 0.92
Head and neck reconstruction with free flaps: a report on 213 cases. Eur Arch Otorhinolaryngol (2007) 0.91
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival. Crit Rev Oncol Hematol (2011) 0.91
Osteosarcomas of the mandible: are they different from other tumor sites? Crit Rev Oncol Hematol (2011) 0.91
Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.90
Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer. Eur Arch Otorhinolaryngol (2013) 0.89
Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology. Clin Imaging (2007) 0.89
Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data. Cancer Genet Cytogenet (2008) 0.89
Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness. PLoS One (2009) 0.88
Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. Int J Radiat Oncol Biol Phys (2013) 0.88
T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otorhinolaryngol (2003) 0.87
Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr Relat Cancer (2011) 0.87
Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol (2009) 0.86
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture. Clin Cancer Res (2012) 0.86
Primary cancer of the sphenoid sinus--a GETTEC study. Head Neck (2009) 0.86
Radical ablative surgery and radial forearm free flap (RFFF) reconstruction for patients with oral or oropharyngeal cancer: postoperative outcomes and oncologic and functional results. Acta Otolaryngol (2009) 0.85
[Parathyroid carcinoma]. Bull Cancer (2006) 0.85